financetom
Business
financetom
/
Business
/
--Chegg Q2 Subscription Services Subscribers at 4.4 Million, Down 9% From Year Earlier and Matching Visible Alpha Analyst Consensus
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Chegg Q2 Subscription Services Subscribers at 4.4 Million, Down 9% From Year Earlier and Matching Visible Alpha Analyst Consensus
Aug 5, 2024 1:18 PM

04:08 PM EDT, 08/05/2024 (MT Newswires) --

Price: 2.9300, Change: -0.01, Percent Change: -0.34

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Quanterix To Acquire Akoya Biosciences
BRIEF-Quanterix To Acquire Akoya Biosciences
Jan 10, 2025
Jan 10 (Reuters) - Akoya Biosciences Inc ( AKYA ): * QUANTERIX TO ACQUIRE AKOYA BIOSCIENCES, CREATING THE FIRST INTEGRATED SOLUTION FOR ULTRA-SENSITIVE DETECTION OF BLOOD- AND TISSUE-BASED PROTEIN BIOMARKERS * QUANTERIX TO ACQUIRE AKOYA BIOSCIENCES, CREATING THE FIRST INTEGRATED SOLUTION FOR ULTRA-SENSITIVE DETECTION OF BLOOD- AND TISSUE-BASED PROTEIN BIOMARKERS * QUANTERIX CORP ( QTRX ) - TO ACQUIRE AKOYA...
BRIEF-CNB Financial And ESSA Bancorp Announce Strategic Merger
BRIEF-CNB Financial And ESSA Bancorp Announce Strategic Merger
Jan 10, 2025
Jan 10 (Reuters) - CNB Financial Corp ( CCNE ): * CNB FINANCIAL CORPORATION AND ESSA BANCORP, INC. ANNOUNCE STRATEGIC MERGER * ESSA BANCORP INC ( ESSA ) - DEAL VALUED AT $214 MILLION, OR $21.10 PER ESSA SHARE * ESSA BANCORP INC ( ESSA ) - SHAREHOLDERS TO RECEIVE 0.8547 CNB SHARES PER ESSA SHARE * ESSA BANCORP INC...
NeoGenomics Appoints Tony Zook as CEO
NeoGenomics Appoints Tony Zook as CEO
Jan 10, 2025
07:34 AM EST, 01/10/2025 (MT Newswires) -- NeoGenomics ( NEO ) said Friday it appointed Tony Zook, an independent board member, to succeed Chris Smith as chief executive officer. Smith will retire from his position, effective April 1, but will stay on as an advisor during the transition to ensure continuity and knowledge transfer, the company said. Zook is a...
Intra-Cellular Therapies, Sandoz Settle CAPLYTA Patent Litigation
Intra-Cellular Therapies, Sandoz Settle CAPLYTA Patent Litigation
Jan 10, 2025
07:36 AM EST, 01/10/2025 (MT Newswires) -- Intra-Cellular Therapies ( ITCI ) said Friday it reached a settlement with Sandoz to resolve patent litigation over its central nervous system disorder drug CAPLYTA. The settlement allows Sandoz to sell generic versions of CAPLYTA starting July 1, 2040, or earlier under specific conditions, the company said. The litigation stemmed from Sandoz's Abbreviated...
Copyright 2023-2026 - www.financetom.com All Rights Reserved